top of page
Health Canada Approves MedMira’s Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health...
MedMira
26. Aug.4 Min. Lesezeit
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 16, 2025  – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has...
MedMira
7. Juli4 Min. Lesezeit
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal® G4 HIV-1/2 rapid test for VA, Department of Defence
Halifax, Nova Scotia, 17th of April, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and Lovell® Government Services announced today that they...
MedMira
17. Apr.3 Min. Lesezeit
MedMira Announces Partnership with MediGroup Physician Services in the United States
Halifax, Nova Scotia, 27th of February, 2025  – MedMira Inc. (MedMira) (TSXV: MIR) announced today its partnership with MediGroup, a...
MedMira
27. Feb.3 Min. Lesezeit
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada.
Halifax, Nova Scotia, 25th of February, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today its exclusive distribution agreement...
MedMira
25. Feb.3 Min. Lesezeit
MedMira Receives Investigational Testing Authorizations for Multiplo® TP/HIV Self-Test and Non-Professional Use Applications
MedMira Receives Investigational Testing Authorizations for Multiplo® TP/HIV Self-Test and Non-Professional Use Applications  Halifax,...
MedMira
21. Jan.5 Min. Lesezeit
bottom of page